Epigenetic priming promotes tyrosine kinase inhibitor resistance and oncogene amplificationRebecca M. Starble(Yale Cancer Center), Andrew Xiao(Yale Cancer Center)Nature Structural & Molecular BiologyOctober 23, 202510.1038/s41594-025-01685-4Cited by 0SaveCiteExport RISWatch citationsRelated PapersN6-methyladenine in DNA antagonizes SATB1 in early development|Nature|2020|90